Shenzhen Transsion Holdings Co., Ltd. (688036.SH): The Stock Exchange of Hong Kong Limited reviews the Company's issuance of H shares.
Shenzhen Transsion Holdings Co., Ltd. (688036.SH) announced that the Company is in the process of applying for the issuance of overseas-listed foreign shares (H shares) and listing on the Main Board of The Stock Exchange of Hong Kong Limited. The Listing Committee of The Stock Exchange of Hong Kong Limited held a listing hearing on September 17, 2026 to review the Company's application for this overseas issuance and listing. The sponsor of the Company's overseas issuance and listing received a letter from The Stock Exchange of Hong Kong Limited on September 18, 2026, which stated that the Listing Committee of The Stock Exchange of Hong Kong Limited has reviewed the Company's listing application, but such letter does not constitute a formal listing approval, and The Stock Exchange of Hong Kong Limited still has the power to raise further comments on the Company's listing application.
Shenzhen Transsion Holdings Co., Ltd. (688036.SH) announced that the Company is proceeding with the relevant work for its application to issue overseas-listed foreign shares (H shares) and to list on the Main Board of The Stock Exchange of Hong Kong Limited. The Listing Committee of The Stock Exchange of Hong Kong Limited held a listing hearing on September 17, 2026 to review the Company's application for this overseas offering and listing. The sponsor of the Company's overseas offering and listing received a letter from The Stock Exchange of Hong Kong Limited on September 18, 2026, which stated that the Listing Committee of The Stock Exchange of Hong Kong Limited has reviewed the Company's listing application, but that such letter does not constitute a formal approval of listing, and The Stock Exchange of Hong Kong Limited still has the power to raise further comments on the Company's listing application.
Related Articles

New Stock News | Zhejiang Jingxin Pharmaceutical (002020.SZ) Files Again with HKEX, Has Successfully Launched Class 1 Innovative Drug Didaxini
.png)
New Stock News | Zhejiang Jingxin Pharmaceutical (002020.SZ) Files Again with the Hong Kong Stock Exchange

CITIC SEC: Ultimate Heat Dissipation Arrives, Diamond Ushers in Its First Year of Industrialization
New Stock News | Zhejiang Jingxin Pharmaceutical (002020.SZ) Files Again with HKEX, Has Successfully Launched Class 1 Innovative Drug Didaxini

New Stock News | Zhejiang Jingxin Pharmaceutical (002020.SZ) Files Again with the Hong Kong Stock Exchange
.png)
CITIC SEC: Ultimate Heat Dissipation Arrives, Diamond Ushers in Its First Year of Industrialization

RECOMMEND





